This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Soy isoflavones
- DrugBank Accession Number
- DB14101
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Synonyms
- Soy germ isoflavones
- Soybean isoflavones
- Soybean isoflavoues
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Menopausal hot flashes •••••••••••• •••••••• ••••••• ••••••• •••• •••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- International/Other Brands
- Solgen 40
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image CALCIBON D SOYA FORTE TABLETAS Soy isoflavones (50 mg) + Calcium citrate tetrahydrate (950 mg) + Cholecalciferol (400 IU) + Magnesium oxide (50 mg) Tablet Oral ALTEA FARMACEUTICA S.A. 2012-10-12 Not applicable Colombia 
Cheon Shim Bo Yun Soy isoflavones (30 mg/1) + D-alpha-Tocopherol acetate (3 mg/1) + N-Acetylglucosamine (263 mg/1) Capsule Oral Saimdang Cosmetics Co., Ltd 2010-11-08 Not applicable US 
D-Cal SoyCal Soy isoflavones (1 g/1) + Calcium carbonate (28.32 g/1) + Cholecalciferol (480 ug/1) Tablet Oral A&Z Pharmaceutical, Inc. 2010-01-22 2018-11-01 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cheon Shim Bo Yun Soy isoflavones (30 mg/1) + D-alpha-Tocopherol acetate (3 mg/1) + N-Acetylglucosamine (263 mg/1) Capsule Oral Saimdang Cosmetics Co., Ltd 2010-11-08 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 71B37NR06D
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Soybean
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, film coated Oral 80 mg Tablet, coated Oral 80 mg Capsule Oral Tablet Oral Capsule, coated Oral 117.85 mg Tablet, coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 20, 2018 15:19 / Updated at June 12, 2020 16:53